Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

194 results about "Lactobacillus gasseri" patented technology

Lactobacillus gasseri is a species in the genus Lactobacillus. It is part of the vaginal flora. Its genome has been sequenced. L. gasseri is a normal inhabitant of the lower reproductive tract in healthy women. It also produces Lactocillin.

Lactobacillus gasseri FMTA1125B with effect of preventing, relieving or treating vaginitis and application of lactobacillus gasseri FMTA1125B

The invention relates to lactobacillus gasseri FMTA1125B with the effect of preventing, relieving or treating vaginitis and application of the lactobacillus gasseri FMTA1125B. The lactobacillus gasseri FMTA1125B is classified and named as lactobacillus gasseri, and the preservation number of the lactobacillus gasseri FMTA1125B is CGMCC No.34292. The lactobacillus gasseri FMTA1125B has the effects of preventing, relieving or treating vaginitis and the application of the lactobacillus gasseri FMTA1125B. The bacterium can produce beneficial components such as lactic acid, gamma-aminobutyric acid and hydrogen peroxide through metabolism so as to regulate the genital tract environment and improve the health degree; and the traditional Chinese medicine composition has relatively good bacteriostasis and sterilization effects on common vaginal pathogenic bacteria such as escherichia coli, staphylococcus aureus, gardnerella vaginalis, candida albicans, neisseria gonorrhoeae and the like. Therefore, the lactobacillus gasseri FMTA1125B strain can be used for preparing a preparation with the effect of improving related genital tract diseases such as vaginitis.
Owner:BEIJING FUMART BIOTECHNOLOGY CO LTD

Probiotic agent for regulating intestinal environment and application thereof

The invention relates to a probiotic agent for regulating an intestinal environment and an application of the probiotic agent. The bacterial strains in the probiotic agent for regulating the intestinal environment comprise a Bifidobacterium animalis subsp. Lactis C-1 bacterial strain and a Lactobacillus gasseri CKCC 1913 bacterial strain, and the bacterial strains in the probiotic agent for regulating the intestinal environment comprise a lactobacillus plantarum subsp. Lactis C-1 bacterial strain and a lactobacillus gasseri CKCC 1913 bacterial strain, a lactobacillus plantarum subsp. Lactis CKCC 1913 bacterial strain, a lactobacillus plantarum subsp. Lactis CKCC 1913 bacterial strain and a lactobacillus plantarum subsp. Lactis CKCC 1913 bacterial strain. A synergistic interaction relationship exists between the two bacteria, so that the intestinal micro-ecological environment can be regulated, the intestinal injury can be relieved and the intestinal barrier function can be improved by reducing the level of inflammatory factors, balancing the content of gastrointestinal regulatory peptides, promoting intestinal peristalsis and other action mechanisms. Therefore, the probiotic agent is suitable for preparing a preparation with the efficacy of preventing, improving or treating constipation and other inflammatory diseases.
Owner:CLASSY KISS YOGURT(SUZHOU) CO LTD +1

Lactobacillus gasseri capable of improving expression of host antibacterial peptide Cathelicidin and secretory immunoglobulin sIgA and enhancing infection resistance by oral administration and external application and metagen of lactobacillus gasseri capable of improving expression of host antibacterial peptide Cathelicidin and secretory immunoglobulin sIgA

PendingCN119931870AAntibacterial agentsBacteriaReceptorVaginal tissue
The invention discloses lactobacillus gasseri capable of improving expression of host antibacterial peptide Cathelicidin and secretory immunoglobulin sIgA and enhancing infection resistance by oral administration and external application and a metagen thereof, and belongs to the technical field of microorganisms. The lactobacillus gasseri disclosed by the invention can be used for promoting the generation of a vaginal epithelial cell antibacterial peptide Cathelicidin; the shedding of vaginal epithelial cells is reduced, the fungal load is reduced, and the generation of vaginal tissue antibacterial peptide CRAMP is improved; the pIgR and immune globulin content of the vaginal tissue is increased; the invention also finds that the lactobacillus gasseri for external use can regulate and control TLR2 (Toll-Like Receptor 2), and further has a good balancing effect on body immunity. Therefore, the lactobacillus gasseri has a huge application prospect in a product for improving the pathogenic bacterium infection resistance of a host, enhancing the self-defense capability and inhibiting the vagina inflammation.
Owner:JIANGNAN UNIV

Combined fungicide for improving Alzheimer disease and application thereof

The invention relates to the technical field of probiotics, in particular to a combined fungicide for improving Alzheimer's disease and application of the combined fungicide. The combined microbial agent is prepared from lactobacillus gasseri LFLG-245 and inactivated Ackermania muciniphila AKKLF (Ackermania muciniphila AKKLF); the lactobacillus gasseri LFLG-245 is preserved in the China General Microbiological Culture Collection Center on March 24, 2025, and the preservation number of the lactobacillus gasseri LFLG-245 is CGMCC (China General Microbiological Culture Collection Center) No.33952. The lactobacillus gasseri LFLG-245 has the advantages that the lactobacillus gasseri LFLG-245 is preserved in the China General Microbiological Culture Collection Center; the Akkermansia muciniphila AKKLF is preserved in the China General Microbiological Culture Collection Center on March 24, 2025, and the preservation number of the Akkermansia muciniphila AKKLF is CGMCC (China General Microbiological Culture Collection Center) No.33955. The Akkermansia muciniphila AKKLF disclosed by the invention has the advantages that the Akkermansia muciniphila AKKLF can be applied to the field of biological The combined microbial agent provided by the invention can improve the Alzheimer's disease.
Owner:GUANGZHOU LIKEFOOD BIOTECH CO LTD

Bacteria with lipid metabolism disease improving capacity and application thereof

The invention belongs to the field of microorganisms and the technical field of medicines, and particularly relates to a bacterium capable of improving lipid metabolism diseases and application of the bacterium. The bacterium capable of improving the lipid metabolism disease is lactobacillus gasseri SPUB4211, has been preserved in the China General Microbiological Culture Collection Center on October 30, 2023, and has the preservation number of CGMCC NO.28809. The lactobacillus gasseri SPUB4211 has been preserved in the China General Microbiological Culture Collection Center; or the lactobacillus gasseri SPUB4209 is preserved in the China General Microbiological Culture Collection Center on October 30, 2023, and the preservation number is CGMCC (China General Microbiological Culture Collection Center) NO.28808. The lactobacillus gasseri SPUB4209 has been preserved in the China General Microbiological Culture Collection Center). The lactobacillus gasseri SPUB4211 and the lactobacillus gasseri SPUB4209 provided by the invention have relatively strong lipid metabolism improving capability, and are verified by respectively detecting biochemical indexes of serum and biochemical indexes in liver of mice in a high fat diet induced hyperlipidemia model and a non-alcoholic fatty liver disease model and by liver tissue slices, and the lactobacillus gasseri SPUB4211 and the lactobacillus gasseri SPUB4209 have good artificial gastric juice, good anti-inflammatory and anti-inflammatory effects and good anti-inflammatory and anti-inflammatory effects. And artificial intestinal juice tolerance.
Owner:SHENYANG PHARMA UNIV

Lactobacillus composition and use thereof

A lactobacillus composition and the use thereof in hyperuricemia, relating to the field of microorganisms. The composition comprises Lactobacillus gasseri BDUP, Lactobacillus fermentum B1B26 and Lactobacillus agilis B13T4. The lactobacillus composition can significantly inhibit the activity of xanthine oxidase XOD in vitro, and, as proved by in-vivo experiments, said probiotic composition can also reduce the content of uric acid in Danio rerio having high uric acid levels and in hyperuricemia model mice and reduce the level of inflammatory factors in mice with hyperuricemia. In addition, the composition has effects obviously superior to that of a single strain and therefore has good development and utilization prospects for treating or preventing and relieving hyperuricemia.
Owner:BEIJING QUANTIHEALTH TECH CO LTD

Rumen methane inhibitor and application thereof

The invention provides a rumen methane inhibitor and application thereof, and belongs to the field of ruminant breeding. The rumen methane inhibitor disclosed by the invention is prepared from the following active ingredients: a lactobacillus reuteri microbial agent, a lactobacillus gasseri microbial agent, a lactobacillus casei microbial agent, amylase, phytase, xylanase, cellulase and beta-glucanase; the rumen methane inhibitor can effectively regulate intestinal microbial populations of dairy cows, promote decomposition of celluloses in rumens of the dairy cows and optimize a rumen fermentation environment, so that the rumen function is controlled, methane production is reduced, and the productivity level of ruminants is improved; the rumen methane inhibitor is safe and environment-friendly, is beneficial to application in the fields of ruminant animal breeding, agriculture and the like, and has good practicability.
Owner:SHENZHEN WANWU HESHENG TECHNOLOGY CO LTD +1

Lactobacillus gasseri and application thereof

The invention provides lactobacillus gasseri which is preserved in the general microbiological center of the China Committee for Culture Collection of Microorganisms on February 7, 2023, and the preservation number is CGMCC (China General Microbiological Culture Collection Center) No.26504. The lactobacillus gasseri has the advantages that the lactobacillus gasseri can be used for preparing the lactobacillus gasseri; the lactobacillus gasseri has a relatively strong inhibition effect on pathogenic bacteria such as Gardneria vaginalis, Escherichia coli, staphylococcus aureus and two-way Pleuromycosis, and also has a certain inhibition effect on CA, so that the lactobacillus gasseri has the effects of killing pathogenic bacteria, improving the host mucosal immunity and resisting infection, and has a good application prospect in the field of animal husbandry, animal husbandry, animal husbandry, animal husbandry, animal husbandry, animal husbandry, animal husbandry and animal husbandry. Meanwhile, growth and reproduction of harmful bacteria can be inhibited, vaginal infection is prevented, and inflammation is treated.
Owner:HANGZHOU GRAND BIOLOGIC PHARMA INC

Formula and preparation method of double-bacterium-fermented low-beany-flavor functional soybean milk

The invention discloses a double-bacterium fermented low-beany-flavor functional soybean milk formula and a preparation method thereof. According to the formula, the adding amount of cane sugar is 4.2% of the mass of a mixed solution. The inoculation amount of the compound lactic acid bacteria is 2.8% of the mass of the fermentation substrate. Wherein the compound lactic acid bacteria comprise lactobacillus plantarum JM065 and lactobacillus gasseri JM1, and the ratio of the lactobacillus plantarum JM065 to the lactobacillus gasseri JM1 is 1: 2 according to the mass ratio of the lactobacillus plantarum JM065 to the lactobacillus gasseri JM1. The preparation method comprises the following steps: selecting, blanching, soaking, grinding, homogenizing, sterilizing, cooling, fermenting and after-ripening. The fermentation temperature is 42 DEG C, and the fermentation time is 8 hours. The soybean milk prepared by fermenting the lactobacillus plantarum JM065 and the lactobacillus gasseri JM1 has the characteristics of oxidation resistance, mellow taste, smooth mouthfeel and pure, fragrant and long aftertaste.
Owner:NORTHEAST AGRICULTURAL UNIVERSITY

Lactobacillus rhamnosus JM039 as well as composition and application thereof

The invention belongs to the technical field of probiotic products, and particularly relates to lactobacillus rhamnosus JM039 as well as a composition and application thereof. The preservation number of the lactobacillus rhamnosus JM039 is GDMCC No: 64409. The lactobacillus rhamnosus JM039 is a lactobacillus rhamnosus strain. The composition is prepared from lactobacillus reuteri J1, lactobacillus gasseri JM1, lactobacillus paracasei JY062, lactobacillus paracasei with the preservation number of GDMCC.No.62990, lactobacillus plantarum JY039 and lactobacillus rhamnosus JM039, and is prepared from lactobacillus reuteri J1, lactobacillus gasseri JM1, lactobacillus paracasei JY062, lactobacillus paracasei with the preservation number of GDMCC.No.62990, lactobacillus plantarum The combined bacteria of the six probiotics can improve the levels of anti-inflammatory factors and intestinal epithelium tight junction proteins and reduce the levels of proinflammatory factors and claudin-2 mRNA, so that the intestinal microenvironment homeostasis and intestinal barrier integrity are maintained through double regulation of inflammatory factors and tight junction proteins, and necrotizing enterocolitis can be relieved.
Owner:NORTHEAST AGRICULTURAL UNIVERSITY

Lactobacillus gasseri strain A21120 with anti-oxidation, anti-inflammatory and anti-tumor functions as well as probiotic agent and application of lactobacillus gasseri strain A21120

The invention provides a lactobacillus gasseri strain A21120 with anti-oxidation, anti-inflammatory and anti-tumor functions as well as a probiotic agent and application of the lactobacillus gasseri strain A21120, and belongs to the technical field of functional microorganisms. The strain A21120 is separated and screened from intestinal feces of healthy old people of 100 years old, and belongs to lactobacillus gasseri through morphological identification and molecular identification. The strain has good gastrointestinal fluid resistance and bovine choline resistance and has the potential of colonizing intestinal tracts. The lactobacillus gasseri strain A21120 provided by the invention has bacteriostatic activity, anti-inflammatory activity, anti-oxidation activity and anti-tumor activity, and provides a new way for treatment of clinical related diseases, drug development and preparation of in-vitro preparations or daily necessities.
Owner:GUANGXI ACAD OF SCI +1

Shea butter fermentation liquor as well as preparation method and application thereof

The invention belongs to the technical field of cosmetic raw materials, and particularly relates to shea butter fermentation liquor as well as a preparation method and application thereof. Lactobacillus plantarum, lactobacillus fermentum and lactobacillus gasseri in a specific proportion are adopted to construct a composite fermentation system, acid-resistant aspergillus niger lipase is combined, and shea butter is treated through a one-step fermentation process. By means of the synergistic effect of the three strains and the synergistic effect of the enzyme and the strains, efficient fermentation can be achieved, the content of active ingredients such as polysaccharide, amino acid and polypeptide in fermentation liquor is remarkably increased, meanwhile, the technological process is simple and stable, and the infectious microbe pollution risk is avoided. According to the fermentation liquor prepared by the process, on the basis of enhancing the original moisturizing and soothing effects of the shea butter, the problems of greasy skin feeling and poor permeation and absorption of the shea butter are effectively solved, the shea butter is further endowed with new functions of repairing skin barriers and balancing skin micro-ecology, and the application values of the shea butter and the fermentation liquor are greatly improved.
Owner:NICE ZHEJIANG TECH CO LTD +2

Composition comprising lactobacillus gasseri for preventing and treating sarcopenia

The present invention relates to a composition comprising Lactobacillus gasseri for preventing and treating sarcopenia and, particularly, to: a composition comprising Lactobacillus gasseri BNR17 for preventing, treating or alleviating sarcopenia, a decrease in muscle mass and muscle function, and a decrease in muscular strength and muscular endurance, which are induced by causes such as stress, obesity, aging, drugs, tumors, and the like.
Owner:ACEBIOME INC

Composition for controlling uptake of microparticles

Provided is a composition for controlling uptake of microparticles into a body, the composition containing a lactic acid bacterium. The lactic acid bacterium is preferably any one selected from bacteria belonging to the genus Lactobacillus and bacteria belonging to the genus Streptococcus. For example, the lactic acid bacterium is a bacterium belonging to Lactobacillus delbrueckii, Lactobacillus paracasei, Lactobacillus gasseri, or Streptococcus thermophilus.
Owner:MEIJI CO LTD

Lactobacillus gasseri FMTA1121E with function of regulating vaginal micro-ecological environment and application of lactobacillus gasseri FMTA1121E

The invention relates to lactobacillus gasseri FMTA1121E with an effect of regulating a vaginal micro-ecological environment and application of the lactobacillus gasseri FMTA1121E. The lactobacillus gasseri FMTA1121E is classified and named as lactobacillus gasseri, and the preservation number of the lactobacillus gasseri FMTA1121E is CGMCC No.34962. The lactobacillus gasseri FMTA1121E can be metabolized to generate beneficial components such as lactic acid, gamma-aminobutyric acid and hydrogen peroxide so as to regulate the genital tract environment and improve the health degree; and the bacillus subtilis has excellent bacteriostasis and sterilization effects on various common vaginal pathogenic bacteria such as escherichia coli, staphylococcus aureus, gardnerella vaginalis, candida albicans, neisseria gonorrhoeae and the like. Therefore, the lactobacillus gasseri FMTA1121E strain can be applied to preparation of preparations for preventing and treating related genital tract diseases such as vaginitis.
Owner:BEIJING FUMART BIOTECHNOLOGY CO LTD

Epimedium enzymolysis probiotic fermentation refined extract and preparation method thereof

The invention relates to the technical field of functional food production through microbial fermentation, in particular to a herba epimedii enzymolysis probiotic fermentation refined extract and a preparation method thereof.The preparation method comprises the following steps that herba epimedii and beta-cyclodextrin are mixed, an obtained mixed solution is subjected to enzymolysis treatment through pectinase, cellulase and glycosidase and then serves as a solid-state fermentation substrate, and the herba epimedii enzymolysis probiotic fermentation refined extract is obtained; adding mixed bacteria of lactobacillus casei, bifidobacterium lactis and lactobacillus gasseri, performing solid-state fermentation, and performing vacuum freeze drying to obtain a herba epimedii probiotic fermentation refined extract; the herba epimedii probiotic fermentation refined extract is prepared by adopting an enzymolysis fermentation method in cooperation with a beta-cyclodextrin inclusion technology, the extraction efficiency, the solubility, the biological activity, the stability and other performance of effective components in herba epimedii are improved, the preparation method is simple, and operation is easy and convenient; the used materials are edible, green and safe; the process saves energy consumption, has good environmental benefits, greatly saves manpower and material resources, and can be applied to industrial large-scale production.
Owner:HEALTHYWAY BIO-TECH LTD

Peptide for promoting proliferation of lactobacillus gasseri as well as preparation method and application of peptide

The invention discloses a peptide for promoting proliferation of lactobacillus gasseri as well as a preparation method and application of the peptide. The peptide comprises any one or more amino acid sequences shown in SEQ ID NO.1-17. The molecular weight is 600-1400 Da, the glutamic acid content is 12.70%-48.91%, and the biological degree, the viable count and the nitrogen source utilization rate of the lactobacillus gasseri are remarkably improved. The strain proliferation promoting peptide is high in stability, simple in process and low in production cost, and the precise design theory of a high-density culture nitrogen source of lactobacillus gasseri is further improved; and scientific theoretical support is provided for design of an optimal culture medium and acquisition of high biomass through a fermentation engineering technology.
Owner:YANGZHOU YANGDA KANGYUAN DAIRY

Application of breast milk-sourced lactobacillus gasseri in reducing weight, reducing blood fat, preventing and treating type 2 diabetes mellitus, relieving intestinal leakage and inhibiting intestinal pathogenic bacteria

ActiveCN119120267AImprove toleranceThe ability to well tolerate the adverse environment of the human digestive tractAntibacterial agentsBacteriaBiotechnologyLow density lipoprotein cholesterol
The invention discloses application of breast milk-derived lactobacillus gasseri in reducing weight, reducing blood fat, preventing and treating type 2 diabetes mellitus, relieving intestinal leakage and inhibiting intestinal pathogens, and belongs to the technical field of microorganisms and the technical field of medicines. The invention provides a new application of lactobacillus gasseri in reducing weight, reducing blood fat, preventing and treating type 2 diabetes, relieving intestinal leakage and inhibiting intestinal pathogens. The traditional Chinese medicine composition can effectively prevent weight gain, body fat rate increase, low-density lipoprotein cholesterol and triglyceride increase of mice caused by high-fat diet, inhibit postprandial blood sugar and insulin resistance index increase, inhibit intestinal mucosa damage and growth of intestinal pathogenic bacteria, and effectively improve chronic diseases of mice with high-fat diet. Therefore, the lactobacillus gasseri FN136 has a huge application prospect in preparation of products for reducing weight, reducing blood fat, preventing and treating type 2 diabetes mellitus, relieving intestinal leakage and inhibiting intestinal pathogens.
Owner:SHANGPIN HEALTH TECH (QINGDAO) CO LTD

Fermentation method and application of Lactobacillus gasseri JM1

The invention discloses a fermentation method of Lactobacillus gasseri JM1 and its application, belonging to the field of microbial technology. The fermentation method comprises the following steps: mixing high-soluble kudzu root bean powder with water in a mass volume ratio of 1:10 g / mL to obtain a mixed solution, adding a composite prebiotic equivalent to 4 wt% of the mixed solution, wherein the composite prebiotic is a mass ratio of oligofructose:inulin:oligogalactose=2:2:1, and inoculating Lactobacillus gasseri JM1 after shaking and mixing, wherein the total viable count of Lactobacillus gasseri JM1 is 1×10 7 CFU / mL, ferment at 37°C until the pH at the end of fermentation is 4.50±0.05. The present invention lays a foundation for the future study of the antioxidant activity of new soy milk. The present invention determines the calcium content in soy milk and finds that the addition of composite prebiotics, synergistic with Lactobacillus gasseri JM1 and kudzu root in soy powder, significantly increases the calcium content in soy milk.
Owner:NORTHEAST AGRICULTURAL UNIVERSITY

Scalp care solution with effects of controlling oil, relieving, inhibiting bacteria and regulating scalp micro-ecology as well as preparation method and application of scalp care solution

The invention discloses a scalp care solution with the effects of controlling oil, relieving, inhibiting bacteria and adjusting scalp micro-ecology and a preparation method and application thereof.The preparation method of the scalp care solution comprises the following steps that a fermentation substrate is inoculated with saccharomycetes, primary fermentation culture is conducted for 24-72 h, then secondary fermentation culture is conducted through Lactobacillus gasseri, and the scalp care solution is obtained; wherein the fermentation substrate comprises rice, barley seeds and water; wherein the saccharomycetes comprise Saccharomyces cerevisiae (Saccharomyces cerevisiae) and Saccharomyces fibulligera (Saccharomyces fibulligera), and the saccharomycetes comprise Saccharomyces cerevisiae (Saccharomyces fibulligera) and Saccharomyces fibulligera (Saccharomyces fibulligera). The rice and the barley seeds are fermented in a microbial fermentation mode, the bioavailability of the rice and the barley seeds is improved, the content of active ingredients in the fermentation liquor prepared through the fermentation technology is increased, the fermentation liquor has the ideal effects of controlling oil, resisting inflammation, inhibiting bacteria, adjusting scalp micro-ecology and the like, the preparation technology is simple, and the method is suitable for industrial production. The fermentation conditions are mild, no organic solvent is used, and safety is achieved.
Owner:BEISHANG JIAMEI (BEIJING) TECH CO LTD +1

Antiallergic probiotic composition as well as preparation method and application thereof

PendingCN119498519AGood anti-food allergy performanceImproved anti-food allergy performanceNatural extract food ingredientsFood ingredient functionsBiotechnologyLactobacillus rhamnosus
The invention discloses an anti-allergic probiotic composition as well as a preparation method and application thereof. The probiotic composition is prepared from the following raw materials in parts by weight: 10 to 50 parts of lactobacillus reuteri PG-LRL116, 10 to 50 parts of lactobacillus acidophilus, 10 to 50 parts of lactobacillus rhamnosus, 10 to 30 parts of lactobacillus gasseri, 10 to 30 parts of lactobacillus salivarius, 5 to 15 parts of cordyceps militaris aqueous extract, 5 to 15 parts of rosemary aqueous extract and 5 to 15 parts of dendrobium huoshanense yeast. The preparation method of the probiotic composition comprises the following steps: preparing the cordyceps militaris aqueous extract, the rosemary aqueous extract and the dendrobium huoshanense yeast; the preparation method comprises the following steps: uniformly mixing lactobacillus reuteri PG-LRL116, lactobacillus acidophilus, lactobacillus rhamnosus, lactobacillus gasseri, lactobacillus salivarius, a cordyceps militaris aqueous extract, a rosemary aqueous extract and a dendrobium huoshanense fermentation product, so as to prepare the anti-allergic probiotic composition. The probiotic composition disclosed by the invention can be used for effectively inhibiting the occurrence of food sensitization reaction.
Owner:苏州信思科技有限公司

Composition for dendritic cell activation, method for producing fermented milk for dendritic cell activation, and composition for promoting secretion of siga in saliva

PCT designated stage expiredWO2025041814A1Milk preparationBacteriaBiotechnologyLactobacillaceae
The present invention addresses the problem of providing a composition for dendritic cell activation that is highly safe and can be more easily ingested by many people. The composition for dendritic cell activation according to the present invention includes an exopolysaccharide produced from a Lactobacillaceae-family lactic acid bacterium. Moreover, the Lactobacillaceae-family lactic acid bacterium is preferably a Lactobacillus-genus lactic acid bacterium or a Lacticaseibacillus-genus lactic acid bacterium, and is preferably Lactobacillus delbrueckii, Lactobacillus delbrueckii subspecies bulgaricus, Lactobacillus gasseri, Lactobacillus paragasseri, or Lacticaseibacillus paracasei.
Owner:MEIJI CO LTD +1

Probiotic composition and application thereof in preparation of products for preventing and treating vagina inflammation

According to the probiotic composition and the application of the probiotic composition in preparation of products for preventing and treating vagina inflammation, the probiotic composition composed of lactobacillus gasseri B13.52 and lactobacillus mucus B14.46 screened from vaginal secretion of healthy women can effectively inhibit growth of escherichia coli, gardnerella and prevotella; the secretion of proinflammatory factors in vaginal epithelial cells can be obviously reduced, so that an anti-inflammatory effect is achieved.
Owner:MBIOU

Postbiotic preparation for improving frequent micturition, dysuria and urine stranguria and maintaining prostate as well as preparation method and application of metabiotic preparation for improving frequent micturition, dysuria and urine stranguria

The invention belongs to the technical field of microorganisms and biological medicines, and particularly relates to a metastatic preparation for improving frequent micturition, dysuria and urination and maintaining prostate as well as a preparation method and application of the metastatic preparation. A strain of lactobacillus gasseri is obtained through screening, it is further verified that a co-fermentation product of the lactobacillus gasseri, lactobacillus reuteri and lactobacillus paracasei shows a synergistic effect, the three kinds of lactobacillus promote and cooperate with one another in the co-fermentation process, the physiological activity of the three kinds of lactobacillus is enhanced, and then the overall probiotic effect is improved. The co-fermentation product of the three kinds of lactobacillus not only has the effects of promoting intestinal health and enhancing the immune function, but also can inhibit inflammatory response, improve the intestinal environment and provide comprehensive health guarantee for human bodies. The synergistic effect provides more comprehensive and effective guarantee for prostate maintenance, and new vitality is injected for prostate health maintenance, so that the composition has good practical application value.
Owner:SHANDONG NICE HEALTH TECHNOLOGY CO LTD

Lactobacillus gasseri BDUP, use thereof and product thereof

PCT designated stage expiredWO2025011582A1Nervous disorderBacteriaMedicineMicrobiology
Lactobacillus gasseri BDUP, the use thereof and a product thereof. The Lactobacillus gasseri BDUP can be used for producing GABA and preventing and / or treating depression. The Lactobacillus gasseri BDUP can produce GABA at a high yield under the condition of not additionally adding glutamic acid, can improve depressive behaviors of mice, and can provide potential strains for probiotic treatment for stress mood disorders such as depression and insomnia, and therefore has great potential market value.
Owner:BEIJING QUANTIHEALTH TECH CO LTD

Preparation method and application of white tea fermentation liquor with effects of controlling oil and removing acne

The invention discloses a preparation method and application of white tea fermentation liquor with oil control and acne removal effects, lactobacillus plantarum and lactobacillus gasseri are adopted to ferment white tea, other organic reagents do not need to be added, conditions are mild in the fermentation process, the structure of active ingredients of the white tea is not damaged, and the natural activity of the white tea is kept. The production cost is saved, the stability of the product quality is fully guaranteed, chemical components such as essence are not added into the fermentation primary pulp, and the safety to a human body is improved; the white tea can be directly used as a skin care product, and the white tea fermentation liquor is rich in polyphenols, amino acids and the like, and has a synergistic effect with some fermentation product probiotics in the fermentation liquor, so that a stronger effect is shown.
Owner:RAYTING BIOTECHNOLOGY CO LTD

Lactobacillus gasseri JY01 and application thereof

The invention provides lactobacillus gasseri JY01, and belongs to the technical field of probiotic application, the lactobacillus gasseri JY01 is preserved in Guangdong Microbial Culture Collection Center on May 21, 2025, the preservation number is GDMCC NO. 66341, and the nucleotide sequence is shown as SEQ ID No: 1. The strain is obtained by separating and purifying a pickle sample produced in Liaoning region of China, has multiple functions of producing gamma-aminobutyric acid (GABA) at high yield, reducing blood sugar, resisting oxidation, regulating gastrointestinal tracts and the like, and has very high application value and economic value.
Owner:JIANGSU JIANQIXING BIOTECHNOLOGY CO LTD

Lactobacillus gasseri capable of improving memory and promoting growth and metagen of lactobacillus gasseri

The invention discloses a lactobacillus gasseri strain capable of improving memory and promoting growth and a metagen thereof, and belongs to the technical field of microbial fermentation. A strain of lactobacillus gasseri is obtained through screening, thalli and metabiotics of the thalli are obtained through culture, the metabiotics and the reed rhizome extract form the compound, and the compound shows a synergistic interaction effect which is specifically shown as follows: in a water maze test, the incubation period of a mouse is shortened; in a rat growth test, the body length, the body width and the testis weight of the rat are all improved. The lactobacillus gasseri and the preparation method thereof have practical value on comprehensive utilization of lactobacillus gasseri and the metaplasts thereof, and also have important value in the aspects of improving memory of an organism and promoting growth.
Owner:胃早安健康科技(山东)有限公司

Female prebiotic wet toilet paper and preparation method thereof

The invention provides female prebiotic wet toilet paper and a preparation method thereof, and belongs to the technical field of female supplies, the female prebiotic wet toilet paper comprises a wet toilet paper preparation liquid and a carrier, the wet toilet paper preparation liquid comprises probiotic powder, and the probiotic powder comprises lactobacillus crispatus powder and lactobacillus gasseri powder. According to the female prebiotic wet toilet paper and the preparation method thereof provided by the invention, the purposes of promoting the growth of beneficial bacteria and maintaining the long-term health of female private parts while achieving the antibacterial effect are achieved.
Owner:YIXIANG HEALTH TECHNOLOGY CO LTD

Composition for preventing or treating sarcopenia containing Lactobacillus gasseri

The present invention relates to a composition for preventing or treating sarcopenia containing Lactobacillus gasseri, and specifically, to a composition for preventing, treating or improving sarcopenia, reduction of muscle mass and muscle function, and reduction of muscle strength and muscle endurance caused by causes such as stress, obesity, aging, drugs, tumors, etc., containing Lactobacillus gasseri BNR17.
Owner:ACEBIOME INC